Dominic Engelhoven

Dominic Engelhoven is currently the Head of Finance Commercial at BioNTech SE, serving as a key financial and strategic advisor within the Global Commercial Leadership Team since January 2022. Previously, Dominic held several prominent roles at Bayer, including Head of Finance for R&D and Regulatory, Medical, Safety & Compliance, as well as leading strategic financial planning and M&A evaluations. With foundational roles in legal entity control and global financial analysis, Dominic's experience spans across various international assignments which began with a Graduate Development Program at Bayer. Educationally, Dominic holds both a Master of Science in International Business - Finance and a Bachelor of Science in International Business, majoring in Finance and minoring in Accounting from Maastricht University School of Business and Economics.